Is this company for real? SEATTLE, Jan. 30, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that it has voluntarily withdrawn its New Drug Application ("NDA") for Pixuvri (pixantrone) for the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL") in patients who failed two or more lines of prior therapy. The NDA was withdrawn because, after communications with the U.S. Food and Drug Administration ("FDA"), CTI needed additional time to prepare for the review of the Pixuvri NDA by the FDA's Oncologic Drugs Advisory Committee ("ODAC") at its February 9, 2012 meeting. Prior to withdrawing the NDA, CTI requested that the FDA consider rescheduling the review of the Pixuvri NDA to the ODAC meeting to be held in late March. The FDA was unable to accommodate CTI's request to reschedule, and given the April 24, 2012 Prescription Drug User Fee Act ("PDUFA") date, the only way to have Pixuvri possibly considered at a later ODAC meeting was for CTI to withdraw and later resubmit the NDA. CTI plans to resubmit the NDA in 2012.
Ha Ha! This group of crooks and snake-oil salesman is getting what it deserves. This is the 3rd time they have tried to push this piece of shit drug thru the FDA and it again is a complete failure. maybe jim Bianco will now stop selling/offering stock to make sure he gets his 6 figure salary and go bankrupt like they should have done yrs ago. It couldn't have happened to a more rotten bunch of people. I guess CTI will now finally dry up and blow away!!! See ya Jimmy Boy!!!!!!!!
Don't count on it...this company is like cockroaches---they live against all odds...they figure out how to extort $$ from somebody to go on...
